Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Aug;67(8):963-8.
doi: 10.6061/clinics/2012(08)18.

Malignant peripheral nerve sheath tumors: clinicopathological aspects, expression of p53 and survival

Affiliations

Malignant peripheral nerve sheath tumors: clinicopathological aspects, expression of p53 and survival

Karin S G Cunha et al. Clinics (Sao Paulo). 2012 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported.

Figures

Figure 1
Figure 1
Malignant triton tumor: case 4 (A and B). A. Area of differentiation in the rhabdomyosarcoma (arrows); H&E, 40x. B. Cells immunopositive for desmin; immunohistochemistry (diaminobenzidine), 40x. C. Malignant peripheral nerve sheath tumor with heterologous differentiation in a chondrosarcoma: case 13; H&E, 20x. D. p53-immunopositive plexiform neurofibroma (arrow); immunohistochemistry (diaminobenzidine), 40x. E. Malignant peripheral nerve sheath tumor immunoreactive for p53: case 24; immunohistochemistry (diaminobenzidine), 40x. F. Malignant peripheral nerve sheath tumor immunoreactive for p53: case 4; immunohistochemistry (diaminobenzidine), 40x. OBS: positive cells in brown.

Similar articles

Cited by

References

    1. Scheithauer BW, Woodruff JM, Erlandson RA.Primary malignant tumors of peripheral nerve Tumors of the peripheral nervous system. Washington, DC: Amer Registry of Pathology; 1999. p.303–72.
    1. Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer. 1986;57(10):2006–21. - PubMed
    1. Friedman JM, Gutmann DH, Maccollin M, Riccardi VM. Johns Hopkins University Press; 1999. Neurofibromatosis: phenotype, natural history, and pathogenesis.
    1. Serra E, Puig S, Otero D, Gaona A, Kruyer H, Ars E, et al. Confirmation of a double-hit model for the NF1 gene in benign neurofibromas. Am J Hum Genet. 1997;61(3):512–9. - PMC - PubMed
    1. Karube K, Nabeshima K, Ishiguro M, Harada M, Iwasaki H. cDNA microarray analysis of cancer associated gene expression profiles in malignant peripheral nerve sheath tumours. J Clin Pathol. 2006;59(2):160–5. - PMC - PubMed

Substances